<DOC>
	<DOCNO>NCT00818558</DOCNO>
	<brief_summary>The aim study , ) ass presence frequency CTC NSCLC patient undergo surgery use cytopathological analysis isolation size ( ISET method ) , , ii ) correlate presence CNHC pTNM stage , histological subtype , percentage tumor cell present primary tumor .</brief_summary>
	<brief_title>The Method ISET ( Insulation Size Epithelial Tumor Cells )</brief_title>
	<detailed_description>Lung cancer prevalent neoplasm major cause tumor-related mortality worldwide . Despite recent advance management resect lung cancer ( i.e. , use adjuvant therapy ) effective treatment metastatic tumor ( i.e. , molecular target agent ) , cure rate patient lung cancer remain low ( . Histological classification lung tumor distinguish small ( SCLC ) non-small cell lung cancer ( NSCLC ) . Most NSCLC display three histological subtypes : adenocarcinoma , squamous cell carcinoma large cell carcinoma . The prognosis three NSCLC subtypes quite similar . In regard , development validation new prognostic/predictive biomarkers tumor tissue biological fluid one promise domain translational cancer research . However , clinical impact new biomarkers carefully validate , include NSCLC . While pTNM stag currently validate prognostic factor use NSCLC patient follow treatment , 25 % 50 % patient early-stage I NSCLC show tumor recurrence follow extensive tumor resection , indicate urgent need sensitive prognostic marker . Furthermore , report presence occult metastatic disease correlate disease recurrence stage I NSCLC patient . There sizable body evidence metastasis could develop circulate tumor cell ( CTC ) spread blood surgery . Thus , sensitive specific detection CTC blood consider potentially relevant predictive biomarker patient NSCLC . Indeed , main goal preoperative detection CTC identify patient high risk recurrence surgery , order perform adapt therapeutic strategy . Despite several study report CTC detection , methodological aspect concern sensitivity , specificity reproducibility prevent clear appraisal clinical impact . While RT-PCR immune-mediated method sensitive , specificity remain critical issue approach transcript antigen know present specifically recognize tumor cell solid tumor . In set , cytopathological analysis circulate non hematological cell ( CNHC ) , epithelial ( CEC ) endothelial ( CEN-C ) origin , isolate accord size ( ISET , Isolation Size Epithelial Tumor cell ) consider promising approach , CNHC enrichment sensitive cell morphology damage allow apply classical cytopathological criterion identify tumor cell . In regard , ISET technology previously report allow identification CTC patient liver breast tumor . However , ISET method never use detect CTC patient NSCLC . The aim study determine diagnostic potential ISET method preoperative detection CTC NSCLC patient . For purpose cytomorphological criterion establish group 10 cytologist classify CNHC 3 group : ) CNHC malignant feature ( CNHC-MF ) , ii ) CNHC uncertain feature ( CNHC-UMF ) , , iii ) CNHC benign feature ( CNHC-BF ) . The presence number circulate cell correlate pTNM , histological subtype , percentage tumor cell primary tumor .</detailed_description>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>For patient : patient operate strong suspicion suspicion malignant tumoral hurt correspond primitive carcinoma small cell lung For control subject : Tabagical patient ( 10 30 package year ) unhurt malignant mild tumoral pathology patient must benefit surgical operation extract hurt lung parenchymateuse tumoral hurt Patient histories cancer synchronous cancer Patient carcinomas small cell , bronchioloalveolar carcinoma , type tumor ( lymphomes , sarcoma , etc. ) . Patient neoadditives treatment Patient accord treatment additives others protocol codify ( particular , platinum navelbine gemcitabine platinum ) stag II</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>non small cell lung cancer</keyword>
</DOC>